7th Aug 2025 · SEBI-Registered Analyst
"Invest like HNIs" by Clovek · 7th Aug 2025
AMBUJACEM Results
AMBUJACEM reported record revenue and EBITDA growth, received statutory approvals for mergers, and gained market share. They aim for 118 MTPA capacity by FY26 and maintain high credit ratings.
#StockInNews#WatchOutFor#FundamentalViews#MacroViews#EquityResearch
499 likes·76 comments